DAM also exhibits upregulation of genes involved in lipid metabolism, phagocytic and lysosomal, pathways such as Apoe, Ctsd, Lpl, Tyrobp, and Trem2, which are known AD risk factors. The gene discussed is TYROBP; the disease is Alzheimer disease.